{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:55:18Z","timestamp":1789073718318,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-025-02173-7","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T01:09:51Z","timestamp":1771376991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Precision medicine in sepsis: reappraising glucocorticoid therapy through the lens of molecular endotypes"],"prefix":"10.1007","volume":"75","author":[{"given":"Jiaqi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinkang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"2173_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:8.","journal-title":"JAMA"},{"issue":"7","key":"2173_CR2","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1080\/00325481.2024.2388021","volume":"136","author":"L Desposito","year":"2024","unstructured":"Desposito L, Bascara C. Review: sepsis guidelines and core measure bundles. Postgrad Med. 2024;136(7):702\u201311.","journal-title":"Postgrad Med"},{"issue":"11","key":"2173_CR3","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063\u2013143.","journal-title":"Crit Care Med"},{"issue":"9","key":"2173_CR4","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378(9):809\u201318.","journal-title":"N Engl J Med"},{"issue":"2","key":"2173_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa071366","volume":"358","author":"CL Sprung","year":"2008","unstructured":"Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358(2):111\u201324.","journal-title":"N Engl J Med"},{"key":"2173_CR6","doi-asserted-by":"crossref","unstructured":"Keh D, Trips E, Marx G et al. 2016 Effect of hydrocortisone on development of shock among patients with severe sepsis. JAMA .316(17):1775-1785.","DOI":"10.1001\/jama.2016.14799"},{"issue":"9","key":"2173_CR7","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh B, Finfer S, Cohen J, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018;378(9):797\u2013808.","journal-title":"N Engl J Med"},{"issue":"9643","key":"2173_CR8","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0140-6736(08)61452-X","volume":"372","author":"GP Anderson","year":"2008","unstructured":"Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008;372(9643):1107\u201319.","journal-title":"Lancet"},{"issue":"2","key":"2173_CR9","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1097\/PCC.0000000000002198","volume":"21","author":"SL Weiss","year":"2020","unstructured":"Weiss SL, Peters MJ, Alhazzani W, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-Associated organ dysfunction in children. Pediatr Crit Care Med. 2020;21(2):e52\u2013106.","journal-title":"Pediatr Crit Care Med"},{"issue":"9","key":"2173_CR10","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s00134-013-3003-z","volume":"39","author":"A Deep","year":"2013","unstructured":"Deep A, Goonasekera CDA, Wang Y, Brierley J. Evolution of haemodynamics and outcome of fluid-refractory septic shock in children. Intensive Care Med. 2013;39(9):1602\u20139.","journal-title":"Intensive Care Med"},{"key":"2173_CR11","doi-asserted-by":"crossref","unstructured":"Noor A, Liu M, Jarman A, Yamanaka T, Kaul M. Point-of-Care ultrasound use in hemodynamic assessment. Biomedicines 2025;13(6):1426.","DOI":"10.3390\/biomedicines13061426"},{"issue":"7","key":"2173_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T van der Poll","year":"2017","unstructured":"van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17(7):407\u201320.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2173_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1164\/rccm.201910-1911TR","volume":"202","author":"J Joffre","year":"2020","unstructured":"Joffre J, Hellman J, Ince C, Ait-Oufella H. Endothelial responses in sepsis. Am J Respir Crit Care Med. 2020;202(3):361\u201370.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2173_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4161\/viru.26907","volume":"5","author":"M Singer","year":"2013","unstructured":"Singer M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence. 2013;5(1):66\u201372.","journal-title":"Virulence"},{"key":"2173_CR15","doi-asserted-by":"crossref","unstructured":"Qiao X, Yin J, Zheng Z, Li L, Feng X. Endothelial cell dynamics in sepsis-induced acute lung injury and acute respiratory distress syndrome: pathogenesis and therapeutic implications. Cell Communication Signal 2024;22(1):241.","DOI":"10.1186\/s12964-024-01620-y"},{"key":"2173_CR16","doi-asserted-by":"crossref","unstructured":"Kumar V. Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury. Front Immunol 2020;11:1722.","DOI":"10.3389\/fimmu.2020.01722"},{"issue":"1","key":"2173_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/SHK.0000000000000052","volume":"41","author":"H Gomez","year":"2014","unstructured":"Gomez H, Ince C, De Backer D, et al. A unified theory of Sepsis-Induced acute kidney injury. Shock. 2014;41(1):3\u201311.","journal-title":"Shock"},{"issue":"6","key":"2173_CR18","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41569-020-00492-2","volume":"18","author":"SM Hollenberg","year":"2021","unstructured":"Hollenberg SM, Singer M. Pathophysiology of sepsis-induced cardiomyopathy. Nat Reviews Cardiol. 2021;18(6):424\u201334.","journal-title":"Nat Reviews Cardiol"},{"issue":"1","key":"2173_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","volume":"14","author":"P Strnad","year":"2016","unstructured":"Strnad P, Tacke F, Koch A, Trautwein C. Liver \u2014 guardian, modifier and target of sepsis. Nat Reviews Gastroenterol Hepatol. 2016;14(1):55\u201366.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"2173_CR20","doi-asserted-by":"crossref","unstructured":"Tang F, Zhao X-L, Xu L-Y, Zhang J-N, Ao H, Peng C. Endothelial dysfunction: pathophysiology and therapeutic targets for sepsis-induced multiple organ dysfunction syndrome. Biomed Pharmacother 2024;178:117180.","DOI":"10.1016\/j.biopha.2024.117180"},{"key":"2173_CR21","doi-asserted-by":"crossref","unstructured":"Xu Z, Mao C, Su C et al. Sepsis subphenotyping based on organ dysfunction trajectory. Crit Care 2022;26(1):197.","DOI":"10.1186\/s13054-022-04071-4"},{"issue":"11","key":"2173_CR22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nri1943","volume":"6","author":"RS Hotchkiss","year":"2006","unstructured":"Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol. 2006;6(11):813\u201322.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2173_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrneph.2017.165","volume":"14","author":"F Venet","year":"2017","unstructured":"Venet F, Monneret G. Advances in the Understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2017;14(2):121\u201337.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"2173_CR24","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41590-023-01490-5","volume":"24","author":"AJ Kwok","year":"2023","unstructured":"Kwok AJ, Allcock A, Ferreira RC, et al. Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsis. Nat Immunol. 2023;24(5):767\u201379.","journal-title":"Nat Immunol"},{"issue":"12","key":"2173_CR25","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862\u201374.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"2173_CR26","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.7150\/thno.72760","volume":"12","author":"RQ Yao","year":"2022","unstructured":"Yao RQ, Li ZX, Wang LX, et al. Single-cell transcriptome profiling of the immune space-time landscape reveals dendritic cell regulatory program in polymicrobial sepsis. Theranostics. 2022;12(10):4606\u201328.","journal-title":"Theranostics"},{"key":"2173_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321:20.","journal-title":"JAMA"},{"issue":"10","key":"2173_CR28","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","volume":"5","author":"BP Scicluna","year":"2017","unstructured":"Scicluna BP, van Vught LA, Zwinderman AH, et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. Lancet Respiratory Med. 2017;5(10):816\u201326.","journal-title":"Lancet Respiratory Med"},{"key":"2173_CR29","doi-asserted-by":"crossref","unstructured":"Zhang Z, Pan Q, Ge H, Xing L, Hong Y, Chen P. Deep learning-based clustering robustly identified two classes of sepsis with both prognostic and predictive values. eBioMedicine 2020;62.","DOI":"10.1016\/j.ebiom.2020.103081"},{"issue":"4","key":"2173_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","volume":"4","author":"EE Davenport","year":"2016","unstructured":"Davenport EE, Burnham KL, Radhakrishnan J, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respiratory Med. 2016;4(4):259\u201371.","journal-title":"Lancet Respiratory Med"},{"issue":"1","key":"2173_CR31","doi-asserted-by":"publisher","first-page":"24760","DOI":"10.1038\/s41598-025-07398-4","volume":"15","author":"C Sombetzki","year":"2025","unstructured":"Sombetzki C, Palmowski L, Ziehe D, et al. Impact of glucocorticoid receptor polymorphism rs6198 on sepsis survival in a prospective multicenter cohort. Sci Rep. 2025;15(1):24760.","journal-title":"Sci Rep"},{"issue":"8010","key":"2173_CR32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41586-024-07282-7","volume":"629","author":"J-P Auger","year":"2024","unstructured":"Auger J-P, Zimmermann M, Faas M, et al. Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids. Nature. 2024;629(8010):184\u201392.","journal-title":"Nature"},{"key":"2173_CR33","doi-asserted-by":"crossref","unstructured":"He Y-J, Xu J-Q, Sun M-M et al. Glucocorticoid-Induced leucine zipper: a promising marker for monitoring and treating sepsis. Front Immunol 2020;11:606649.","DOI":"10.3389\/fimmu.2020.606649"},{"key":"2173_CR34","doi-asserted-by":"publisher","first-page":"114930","DOI":"10.1016\/j.bcp.2022.114930","volume":"198","author":"I Muscari","year":"2022","unstructured":"Muscari I, Fierabracci A, Adorisio S, et al. Glucocorticoids and natural killer cells: a suppressive relationship. Biochem Pharmacol. 2022;198:114930.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"2173_CR35","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1161\/01.RES.50.6.805","volume":"50","author":"WS Colucci","year":"1982","unstructured":"Colucci WS, Gimbrone MA, McLaughlin MK, Halpern W, Alexander RW. Increased vascular catecholamine sensitivity and alpha-adrenergic receptor affinity in female and estrogen-treated male rats. Circul Res. 1982;50(6):805\u201311.","journal-title":"Circul Res"},{"key":"2173_CR36","doi-asserted-by":"crossref","unstructured":"Annane D. A 3-Level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000;283(8).","DOI":"10.1001\/jama.283.8.1038"},{"issue":"8","key":"2173_CR37","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMra020529","volume":"348","author":"MS Cooper","year":"2003","unstructured":"Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 2003;348(8):727\u201334.","journal-title":"N Engl J Med"},{"issue":"11","key":"2173_CR38","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJM198709103171101","volume":"317","author":"RC Bone","year":"1987","unstructured":"Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987;317(11):653\u20138.","journal-title":"N Engl J Med"},{"key":"2173_CR39","doi-asserted-by":"crossref","unstructured":"He Y, Chen X, Zhong J et al. Glucocorticoid reduces mortality in LPS-induced sepsis mouse model by inhibiting JAK1\/STAT3-mediated inflammatory response and restoring Tricarboxylic acid cycle. Life Sci 2025;375:123744.","DOI":"10.1016\/j.lfs.2025.123744"},{"issue":"11","key":"2173_CR40","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1097\/CCM.0000000000005357","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al. Executive summary: surviving sepsis campaign: international guidelines for the management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):1974\u201382.","journal-title":"Crit Care Med"},{"key":"2173_CR41","doi-asserted-by":"publisher","first-page":"1110516","DOI":"10.3389\/fimmu.2022.1110516","volume":"13","author":"CH Wu","year":"2022","unstructured":"Wu CH, Guo L, Hao D, et al. Relative adrenal insufficiency is a risk factor and endotype of sepsis: a proof-of-concept study to support a precision medicine approach to guide glucocorticoid therapy for sepsis. Front Immunol. 2022;13:1110516.","journal-title":"Front Immunol"},{"key":"2173_CR42","doi-asserted-by":"crossref","unstructured":"Park YJ, Lee MJ, Bae J et al. Effects of glucocorticoid therapy on sepsis depend both on the dose of steroids and on the severity and phase of the animal sepsis model. Life (Basel) 2022;12(3):421.","DOI":"10.3390\/life12030421"},{"issue":"6","key":"2173_CR43","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.chest.2016.11.036","volume":"151","author":"PE Marik","year":"2017","unstructured":"Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J, Hydrocortisone. Vitamin C, and thiamine for the treatment of severe sepsis and septic shock. Chest. 2017;151(6):1229\u201338.","journal-title":"Chest"},{"issue":"1","key":"2173_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0006-2952(98)00121-X","volume":"56","author":"K Okamoto","year":"1998","unstructured":"Okamoto K, Tanaka H, Makino Y, Makino I. Restoration of the glucocorticoid receptor function by the phosphodiester compound of vitamins C and E, EPC-K1 (L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl hydrogen phosphate] potassium salt), via a redox-dependent mechanism. Biochem Pharmacol. 1998;56(1):79\u201386.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2173_CR45","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s00134-024-07733-9","volume":"51","author":"J Rynne","year":"2025","unstructured":"Rynne J, Mosavie M, Masse M-H, et al. Sepsis subtypes and differential treatment response to vitamin C: biological sub-study of the LOVIT trial. Intensive Care Med. 2025;51(1):82\u201393.","journal-title":"Intensive Care Med"},{"key":"2173_CR46","doi-asserted-by":"crossref","unstructured":"Annane D. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288(7):862-871.","DOI":"10.1001\/jama.288.7.862"},{"issue":"1","key":"2173_CR47","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13054-024-05056-1","volume":"28","author":"S Rusev","year":"2024","unstructured":"Rusev S, Thon P, Dyck B, et al. High expression of L-GILZ transcript variant 1 (GILZ TV 1) is associated with increased 30-day sepsis mortality, and a high expression ratio possibly contraindicates hydrocortisone administration. Crit Care. 2024;28(1):270.","journal-title":"Crit Care"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02173-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02173-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02173-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:04:45Z","timestamp":1771419885000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02173-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2173"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02173-7","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent to this publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"38"}}